Perforated intestinal metastasis while taking the BRAF inhibitor, vemurafanib

ANZ J Surg. 2014 Nov;84(11):891. doi: 10.1111/ans.12690.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Intestinal Neoplasms / diagnosis
  • Intestinal Neoplasms / secondary*
  • Intestinal Neoplasms / surgery
  • Intestinal Perforation / chemically induced*
  • Intestinal Perforation / diagnosis
  • Intestinal Perforation / surgery
  • Intestine, Small*
  • Laparotomy
  • Male
  • Melanoma / diagnosis
  • Melanoma / drug therapy
  • Melanoma / secondary*
  • Middle Aged
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Rupture, Spontaneous
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology*
  • Sulfonamides / adverse effects*
  • Sulfonamides / therapeutic use
  • Tomography, X-Ray Computed
  • Vemurafenib

Substances

  • Indoles
  • Sulfonamides
  • Vemurafenib
  • Proto-Oncogene Proteins B-raf